Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)—study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial

Open Access UCL Research: Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)—study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial https://t.co/5Ry5WCyeKm

Publication of authors from #medmuni @FNBrno and @FNUSA and other colleagues about effect of dexamethasone in patients with ARDS and COVID-19 is just out in @BioMedCentral 👉https://t.co/qL5xnSUKBm

V září loňského roku jsme vás informovali o publikaci ke studii REMED, která obsahovala souhrn protokolu tohoto KH. ✍️ Zveřejnění zkrácené verze studie vyvolalo potřebu připravit plnou verzi protokolu, tak tady je! 👉 https://t.co/aobYxusOfk #clinicaltria

Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial https://t.co/ICqn4Ea0dK